APOE and atherosclerosis: [64Cu]Cu-DOTA-CANF-Comb were tested preclinically in apolipoprotein E–deficient (ApoE−/−) mice atherosclerosis model and showed a remarkable sensitivity to detect atherosclerotic plaques [66], enabling a transfer to clinical evaluation (Table 1).